Company / Working Capital
Biohaven Ltd. Working Capital History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$384.2M
FY2024
5-year range
$52.9M / $496.9M
FY2021-FY2024
Trend
-0.7%
vs FY2023
Sector context
#113 of 213
Health Care
What the data says
At $384M, Biohaven Ltd.'s working capital ranks #113 of 213 in the Health Care sector. Declined from $497M to $384M over the past 2 years.
Based on SEC 10-K filings.
$384M in FY2024 with a 3-year CAGR of +93.7%.
Declined from $497M to $384M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +93.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#113 of 213 in Health CareTop 53% of 213This company $384.2M Sector average $934.6M
▼
-58.9% below sector average
Key checks
Key Insights
- 3-year CAGR of +93.7%, indicating consistent growth.
- In FY2024, working capital decreased 0.7% year-over-year.
- Ranks #113 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $384.2M | -0.7% |
| FY2023 | $387.0M | -22.1% |
| FY2022 | $496.9M | +839.6% |
| FY2021 | $52.9M | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026